News
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.
You recently wrote about a study regarding aspirin therapy for people with high Lp(a) levels. What is the current thinking?
Certain food additives and preservatives may also be to blame. Drugs that can cause hives and angioedema include aspirin and other NSAIDs (such as ibuprofen), some high blood pressure medications ...
Hereditary angioedema is characterized by unpredictable swelling involving the face, oropharynx, extremities, or abdomen, without hives or pruritus. Laryngeal attacks carry a risk of asphyxiation, ...
Of the 34 participants, 16 (47.1%) developed periorbital angioedema, with seven (20.6%) reacting to 100 mg cumulative aspirin dose and nine (26.5%) to 150 mg dose. All mucocutaneous reactions were ...
14 One support of this “cyclooxygenase theory” is the demonstration that pretreatment with leukotriene-receptor antagonists can block NSAID-induced urticaria and angioedema reactions. 14 In addition ...
005). Also, they said, there was a strong trend toward decreased risk for hypersensitivity to aspirin with a history of hives and angioedema. But in the multivariate analysis, the researchers said ...
Angioedema associated with angiotensin-converting ... Mastalerz L, Setkowicz M, Sanak M, et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma.
But aspirin therapy comes with its own risks. Regular aspirin use appeared to lower the risk of developing colorectal cancer in a new study. The benefits were most pronounced for people with ...
Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study led by researchers at Mass General Brigham.
BioCryst Pharmaceuticals, Inc. today announced new real-world evidence showing that patients with hereditary angioedema (HAE) who have normal C1-inhibitor (HAE-nC1-INH) level and function had a ...
An antisense oligonucleotide therapy showed efficacy as a prophylactic treatment for hereditary angioedema (HAE), the phase III OASIS-HAE trial showed. The least-squares mean time-normalized HAE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results